21 Stocks to Watch on January 16: Potential for Significant Gains Amid Corporate Updates

• Biocon completed a ₹4,150 crore QIP for balance sheet strengthening and growth.
• Infosys raised its FY26 constant currency revenue growth guidance to 3%-3.5%.
• Zydus Lifesciences received USFDA approval for Eltrombopag Tablets for blood disorders.
• NBCC secured a ₹55.02 crore Project Management Consultancy order from Indian Overseas Bank for a new regional office in Raipur.
• RailTel received an ₹88 crore LoA from Central Railway for technical infrastructure.

Why It Matters: Key corporate updates and financial results position 21 stocks for potential gains or volatility on January 16.